Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Thorac Oncol. 2016 Jan;11(1):e5–e16. doi: 10.1016/j.jtho.2015.08.002

Table 2.

Pre-operative adjuvant therapy and the likelihood of margin positive resection.


Total N Margin Positive Likelihood of Margin Positive
N (%) p value aOR* (95% CI) p value
Pre-operative radiation <.001
 Yes 590 51(8.6) 1.59(1.17–2.15) 0.003
 No 107660 4896(4.6) 1
Pre-operative chemotherapy <.001
 Yes 1640 124(7.6) 1.19(0.98 –1.45) 0.08
 No 107660 4896(4.6) 1
Pre-operative chemoradiation <.001
 Yes 1653 151(9.1) 1.17(0.98–1.41) 0.09
 No 107660 4896(4.6) 1
*

Odds ratio adjusted for age at diagnosis, gender, race/ethnicity, insurance, median income level, urban/rural, histology, tumor grade, tumor size, primary site, T stage, N stage, Surgical type, facility type, proportion of Medicaid/Uninsured, proportion of Lung Cancer surgery, Volume of cancer surgery